Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: A randomized controlled clinical trial
- Resource Type
- Article
- Source
- In
Vaccine 15 January 2015 33(4):559-567 - Subject
- Language
- ISSN
- 0264-410X